Female Powerbrokers Q&A: Wolf Greenfield's Helen Lockhart

Law360, New York (March 18, 2014, 2:46 PM EDT) -- Helen Lockhart is a shareholder in Wolf Greenfield & Sacks PC's Boston office. Her practice involves strategic counseling on development and management of domestic and international intellectual property rights for a variety of clients, including universities, smaller and mid-sized companies, startups, and entrepreneurs.

She has broad experience in prosecuting biotechnology patents relating to immune response modulators, drug delivery, catalytic molecules, antibodies, fluorescence based micro- and nano-analysis, cell culture, mass spectrometry, nucleic acid sequencing, polymer-based and biological-based drug delivery systems, antisense nucleic acid therapeutics, peptides, small molecule...
To view the full article, register now.